Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Roy S. Herbst, MD, PhD, FACP, FASCO
Date of Release
May 14th, 2025
